Da Cheng Xu

Fullgoal Fund Management Co., Ltd. (Fullgoal Fund) is an independent Chinese fund management firm which was founded in 1999. In 2003, the firm was restructured when the Bank of Montreal took a strategic interest in them and brought international concepts and management techniques to Fullgoal Fund. Headquartered in Shanghai, Fullgoal Fund provides investment management solutions including open and closed-end mutual funds, qualified domestic institutional investor (QDII) funds, enterprise annuity funds, domestic social security funds and asset management to segregated accounts for both domestic and international clients.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.

Fullgoal Fund Management Co., Ltd. (Fullgoal Fund) is an independent Chinese fund management firm which was founded in 1999. In 2003, the firm was restructured when the Bank of Montreal took a strategic interest in them and brought international concepts and management techniques to Fullgoal Fund. Headquartered in Shanghai, Fullgoal Fund provides investment management solutions including open and closed-end mutual funds, qualified domestic institutional investor (QDII) funds, enterprise annuity funds, domestic social security funds and asset management to segregated accounts for both domestic and international clients.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.

Fullgoal Fund Management Co., Ltd. (Fullgoal Fund) is an independent Chinese fund management firm which was founded in 1999. In 2003, the firm was restructured when the Bank of Montreal took a strategic interest in them and brought international concepts and management techniques to Fullgoal Fund. Headquartered in Shanghai, Fullgoal Fund provides investment management solutions including open and closed-end mutual funds, qualified domestic institutional investor (QDII) funds, enterprise annuity funds, domestic social security funds and asset management to segregated accounts for both domestic and international clients.

Sinomune Pharmaceutical Co., Ltd. principally engages in the research, development, production, sale, and promotion of functional skin care products as well as medicines in the fields of kidney diseases and skin. The company was founded on March 11, 1999 and is headquartered in Wuxi, China.